Frequency and Determinants of Olfactory Hallucinations in Parkinson's Disease Patients.
Parkinson’s disease
gustatory hallucinations
olfactory dysfunctions
olfactory hallucinations
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
24 Jun 2021
24 Jun 2021
Historique:
received:
27
05
2021
revised:
16
06
2021
accepted:
23
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Olfactory dysfunctions and hallucinations are considered common nonmotor symptoms in Parkinson's disease (PD). Visual and auditory hallucinations are well-known; however, olfactory hallucinations (OHs) are not fully investigated. The aim of this study was to evaluate OHs in PD patients, and their correlation to motor impairment, cognitive abilities, visual and auditory hallucinations, and olfactory and gustatory function. A sample of 273 patients was enrolled: 141 PD patients (mean age ± SD: 70.1 ± 9.5 years) and 132 healthy controls (mean age ± SD: 69.4 ± 9.6 years). In all patients, the following parameters were evaluated: motor symptoms (UPDRS-III), olfactory function, cognitive abilities, and occurrence of OH, gustatory hallucinations (GHs), and visual/auditory hallucinations. OHs were found only in PD patients with a percentage of 11.3%. Among PD patients with OHs, 2.8% also presented GHs. High significant frequencies of females, the presence of visual/auditory hallucinations, and a high mean UPDRS-III score were found in patients with OHs related to patients without them. Binary logistic regression evidenced the presence of visual/auditory hallucinations and sex as main variables predicting the presence of OHs. Our data indicated that OHs occur frequently in PD patients, especially in women, and often concomitant with visual and auditory hallucinations, without any association with olfactory impairment.
Sections du résumé
BACKGROUND
BACKGROUND
Olfactory dysfunctions and hallucinations are considered common nonmotor symptoms in Parkinson's disease (PD). Visual and auditory hallucinations are well-known; however, olfactory hallucinations (OHs) are not fully investigated. The aim of this study was to evaluate OHs in PD patients, and their correlation to motor impairment, cognitive abilities, visual and auditory hallucinations, and olfactory and gustatory function.
METHODS
METHODS
A sample of 273 patients was enrolled: 141 PD patients (mean age ± SD: 70.1 ± 9.5 years) and 132 healthy controls (mean age ± SD: 69.4 ± 9.6 years). In all patients, the following parameters were evaluated: motor symptoms (UPDRS-III), olfactory function, cognitive abilities, and occurrence of OH, gustatory hallucinations (GHs), and visual/auditory hallucinations.
RESULTS
RESULTS
OHs were found only in PD patients with a percentage of 11.3%. Among PD patients with OHs, 2.8% also presented GHs. High significant frequencies of females, the presence of visual/auditory hallucinations, and a high mean UPDRS-III score were found in patients with OHs related to patients without them. Binary logistic regression evidenced the presence of visual/auditory hallucinations and sex as main variables predicting the presence of OHs.
CONCLUSIONS
CONCLUSIONS
Our data indicated that OHs occur frequently in PD patients, especially in women, and often concomitant with visual and auditory hallucinations, without any association with olfactory impairment.
Identifiants
pubmed: 34202903
pii: brainsci11070841
doi: 10.3390/brainsci11070841
pmc: PMC8301996
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Mov Disord. 2007 Apr 30;22(6):839-42
pubmed: 17357143
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
J Neurol. 2019 Feb;266(2):339-345
pubmed: 30488238
Neurology. 2020 Nov 3;95(18):e2500-e2508
pubmed: 32943485
J Chronic Dis. 1975 Oct;28(9):493-7
pubmed: 1176578
J Neurol Sci. 2012 Dec 15;323(1-2):33-9
pubmed: 22935408
Parkinsonism Relat Disord. 2009 Aug;15(7):490-4
pubmed: 19138875
Chem Senses. 2017 May 1;42(4):309-318
pubmed: 28334095
Mov Disord. 2008 Oct 30;23(14):1984-90
pubmed: 18759360
J Neurol Sci. 2017 Mar 15;374:56-62
pubmed: 28108020
Rhinol Suppl. 2017 Mar;54(26):1-30
pubmed: 29528615
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc04
pubmed: 22558054
J Neurol. 2018 Aug;265(8):1764-1771
pubmed: 29804147
Laryngoscope. 2010 Aug;120(8):1707-13
pubmed: 20641087
Neurol Sci. 2015 Feb;36(2):209-14
pubmed: 25139107
J Neurol. 2020 Jan;267(1):57-63
pubmed: 31555978
J Neural Transm (Vienna). 2019 May;126(5):585-595
pubmed: 30911822
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4154-9
pubmed: 11259673
Arch Neurol. 2008 Sep;65(9):1237-9
pubmed: 18779429
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1649-1654
pubmed: 30843174
Eur Arch Otorhinolaryngol. 2007 Mar;264(3):237-43
pubmed: 17021776
Am J Geriatr Psychiatry. 2012 Feb;20(2):123-32
pubmed: 21617521
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):719-728
pubmed: 30554358
Chem Senses. 2019 May 29;44(5):311-318
pubmed: 30944919
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1019-21
pubmed: 22752694
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
BMC Neurol. 2008 Jun 20;8:21
pubmed: 18570642
Mov Disord. 2011 Oct;26(12):2196-200
pubmed: 21755536
Brain Sci. 2020 Apr 07;10(4):
pubmed: 32272584
J Parkinsons Dis. 2012;2(3):199-205
pubmed: 23938227
Parkinsonism Relat Disord. 2018 Sep;54:40-45
pubmed: 29653909